{"id":6301,"date":"2020-07-27T18:00:00","date_gmt":"2020-07-27T18:00:00","guid":{"rendered":"https:\/\/realheart.se\/mfn_news\/retroaktivt-offentliggorande-av-arsredovisning-for-2018\/"},"modified":"2020-07-27T18:00:00","modified_gmt":"2020-07-27T18:00:00","slug":"retroaktivt-offentliggorande-av-arsredovisning-for-2018","status":"publish","type":"mfn_news","link":"https:\/\/realheart.se\/sv\/mfn_news\/retroaktivt-offentliggorande-av-arsredovisning-for-2018\/","title":{"rendered":"Retroaktivt offentligg\u00f6rande av \u00e5rsredovisning f\u00f6r 2018"},"content":{"rendered":"<p><span><span><span><span>Enligt Spotlight Stock Markets regelverk ska Bolagets \u00e5rsredovisningar offentligg\u00f6ras genom ett pressmeddelande vid tidpunkten f\u00f6r n\u00e4r denna l\u00e4ggs upp p\u00e5 bolagets hemsida. Vid en granskning har det framkommit att Bolaget kommunicerat offentligg\u00f6rande i kallelsen till \u00e5rsst\u00e4mman, ej genom ett separat meddelande varvid detta nu justeras retroaktivt. \u00a0\u00a0\u00a0<\/span><\/span><\/span><\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span><span><strong>F\u00f6r ytterligare information kontakta:<\/strong><\/span><\/span><\/p>\n<p><span><span>Azad Najar, VD <\/span><\/span><\/p>\n<p><span><span>Tel: +46(0)736-673\u00a0463<\/span><\/span><\/p>\n<p><span><span>E-post:\u00a0<\/span><a href=\"mailto:azad.najar@realheart.se\" rel=\"nofollow\"><span>azad.najar@realheart.se<\/span><\/a>\u00a0<\/span><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about\">\n<p><span><em>Scandinavian Real Heart AB utvecklar ett komplett artificiellt hj\u00e4rta (Total Artificial Heart \u2013 TAH) f\u00f6r implantation i patienter med livshotande hj\u00e4rtsvikt. Bolagets TAH har en unik, patenterad, design som innefattar en kopiering av det naturliga m\u00e4nskliga hj\u00e4rtat. Real Hearts TAH inf\u00f6rlivar ett fyrkammarsystem (tv\u00e5 f\u00f6rmak, tv\u00e5 kamrar) vilket ger m\u00f6jlighet att generera ett fysiologiskt anpassat blodfl\u00f6de som efterliknar kroppens naturliga cirkulation. Ett koncept som \u00e4r unikt i den medicintekniska v\u00e4rlden. <\/em><em><\/em><\/span><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy\/release.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F12118%2F3160114%2F1284131.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/release.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F12118%2F3160114%2F1284131.pdf&type=jpg\"><\/span>Release<\/a><\/div><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy\/arsredovisning-tryckt-realheart-2018.pdf?url=https%3A%2F%2Fmb.cision.com%2FPublic%2F12118%2F3160114%2F9d45bef5ec6a7f68.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/arsredovisning-tryckt-realheart-2018.pdf?url=https%3A%2F%2Fmb.cision.com%2FPublic%2F12118%2F3160114%2F9d45bef5ec6a7f68.pdf&type=jpg\"><\/span>\u00c5rsredovisning ( tryckt)  Realheart 2018 <\/a><\/div><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy\/realheart-arsredovisning-2018.pdf?url=https%3A%2F%2Fmb.cision.com%2FPublic%2F12118%2F3160114%2Fb3cd8350270186b6.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/realheart-arsredovisning-2018.pdf?url=https%3A%2F%2Fmb.cision.com%2FPublic%2F12118%2F3160114%2Fb3cd8350270186b6.pdf&type=jpg\"><\/span>Realheart \u00e5rsredovisning 2018<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Enligt Spotlight Stock Markets regelverk ska Bolagets \u00e5rsredovisningar offentligg\u00f6ras genom ett pressmeddelande vid tidpunkten f\u00f6r n\u00e4r denna l\u00e4ggs upp p\u00e5 bolagets hemsida. Vid en granskning har det framkommit att Bolaget kommunicerat offentligg\u00f6rande i kallelsen till \u00e5rsst\u00e4mman, ej genom ett separat meddelande varvid detta nu justeras retroaktivt. \u00a0\u00a0\u00a0 F\u00f6r ytterligare information kontakta: Azad Najar, VD Tel:&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-6301","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-report-annual","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-report","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory-vpml"],"acf":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Retroaktivt offentligg\u00f6rande av \u00e5rsredovisning f\u00f6r 2018 - Realheart<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/realheart.se\/mfn_news\/retroaktivt-offentliggorande-av-arsredovisning-for-2018\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Retroaktivt offentligg\u00f6rande av \u00e5rsredovisning f\u00f6r 2018 - Realheart\" \/>\n<meta property=\"og:description\" content=\"Enligt Spotlight Stock Markets regelverk ska Bolagets \u00e5rsredovisningar offentligg\u00f6ras genom ett pressmeddelande vid tidpunkten f\u00f6r n\u00e4r denna l\u00e4ggs upp p\u00e5 bolagets hemsida. Vid en granskning har det framkommit att Bolaget kommunicerat offentligg\u00f6rande i kallelsen till \u00e5rsst\u00e4mman, ej genom ett separat meddelande varvid detta nu justeras retroaktivt. \u00a0\u00a0\u00a0 F\u00f6r ytterligare information kontakta: Azad Najar, VD Tel:...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/realheart.se\/mfn_news\/retroaktivt-offentliggorande-av-arsredovisning-for-2018\/\" \/>\n<meta property=\"og:site_name\" content=\"Realheart\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/retroaktivt-offentliggorande-av-arsredovisning-for-2018\\\/\",\"url\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/retroaktivt-offentliggorande-av-arsredovisning-for-2018\\\/\",\"name\":\"Retroaktivt offentligg\u00f6rande av \u00e5rsredovisning f\u00f6r 2018 - Realheart\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\"},\"datePublished\":\"2020-07-27T18:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/retroaktivt-offentliggorande-av-arsredovisning-for-2018\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/retroaktivt-offentliggorande-av-arsredovisning-for-2018\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/retroaktivt-offentliggorande-av-arsredovisning-for-2018\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Retroaktivt offentligg\u00f6rande av \u00e5rsredovisning f\u00f6r 2018\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\",\"url\":\"https:\\\/\\\/realheart.se\\\/\",\"name\":\"Realheart\",\"description\":\"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/realheart.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Retroaktivt offentligg\u00f6rande av \u00e5rsredovisning f\u00f6r 2018 - Realheart","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/realheart.se\/mfn_news\/retroaktivt-offentliggorande-av-arsredovisning-for-2018\/","og_locale":"sv_SE","og_type":"article","og_title":"Retroaktivt offentligg\u00f6rande av \u00e5rsredovisning f\u00f6r 2018 - Realheart","og_description":"Enligt Spotlight Stock Markets regelverk ska Bolagets \u00e5rsredovisningar offentligg\u00f6ras genom ett pressmeddelande vid tidpunkten f\u00f6r n\u00e4r denna l\u00e4ggs upp p\u00e5 bolagets hemsida. Vid en granskning har det framkommit att Bolaget kommunicerat offentligg\u00f6rande i kallelsen till \u00e5rsst\u00e4mman, ej genom ett separat meddelande varvid detta nu justeras retroaktivt. \u00a0\u00a0\u00a0 F\u00f6r ytterligare information kontakta: Azad Najar, VD Tel:...","og_url":"https:\/\/realheart.se\/mfn_news\/retroaktivt-offentliggorande-av-arsredovisning-for-2018\/","og_site_name":"Realheart","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/realheart.se\/mfn_news\/retroaktivt-offentliggorande-av-arsredovisning-for-2018\/","url":"https:\/\/realheart.se\/mfn_news\/retroaktivt-offentliggorande-av-arsredovisning-for-2018\/","name":"Retroaktivt offentligg\u00f6rande av \u00e5rsredovisning f\u00f6r 2018 - Realheart","isPartOf":{"@id":"https:\/\/realheart.se\/#website"},"datePublished":"2020-07-27T18:00:00+00:00","breadcrumb":{"@id":"https:\/\/realheart.se\/mfn_news\/retroaktivt-offentliggorande-av-arsredovisning-for-2018\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/realheart.se\/mfn_news\/retroaktivt-offentliggorande-av-arsredovisning-for-2018\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/realheart.se\/mfn_news\/retroaktivt-offentliggorande-av-arsredovisning-for-2018\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"MFN News Items","item":"https:\/\/realheart.se\/mfn_news\/"},{"@type":"ListItem","position":2,"name":"Retroaktivt offentligg\u00f6rande av \u00e5rsredovisning f\u00f6r 2018"}]},{"@type":"WebSite","@id":"https:\/\/realheart.se\/#website","url":"https:\/\/realheart.se\/","name":"Realheart","description":"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/realheart.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news\/6301","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/media?parent=6301"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}